Associated Papers
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.
Lee K et al.
Blood, 2024
38985830 (PubMed )
Supplement: BLOOD_BLD-2023-021944-mmc1.pdf
Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing.
Wei J et al.
Plos Biology, 2024
38865309 (PubMed )
Supplement: pbio.3002680.s016.xlsx › ClinVar
Somatic mosaicism and compound heterozygosity in female hemophilia B.
Costa JM et al.
Blood, 2000
Select a paper to view details